Our group conducts research to improve human health by lowering the cost of care, especially for underserved populations, and by developing enabling technologies to accelerate development of therapeutics and biomedical discoveries.

Projects include invention and development of point-of-care devices for in-vitro diagnostics such as the fast screening of diseases and detection of health conditions and disease progression.  We also conduct research to produce unique, cutting-edge biomedical systems such as microfluidic cell sorters, flow cytometers, image-guided cell sorters and single cell analyzers, using the technologies of biophotonics, microfluidics, image processing, and AI/ML.

The technologies invented by our lab have been commercialized and deployed worldwide through the company NanoCellect Biomedical we co-founded (https://nanocellect.com/).  All leading academic labs, hospitals, and the top 50 pharmaceutical companies have been using the microfluidic fluorescence-activated cell sorting (micro-FACS) and image-guided cell sorters for drug development, gene editing, cell therapy, and singe-cell sequencing.